The proceedings are now available:

• Entire proceedings - (16,853 KB)
• Table of Contents
• Proceedings by section:
  • Section I - Smooth Muscle Pharmacology
    • John F. Burka: Use of airway smooth muscle to evaluate anti-inflammatory and anti-asthmatic agents
    • Jerome H. Fleisch: Actions of leukotriene agonists and antagonists on smooth muscle
    • P. D. Conlon: Impairment of homeostasis in airway smooth muscle by pulmonary infection
  • Section II - Eicosanoids
    • Dawn Merton Boothe, Lynn G. Friedlander and William L. Jenkins: Eicosanoids: A selective update
    • P. Lees, A. D. Sedwick, A. J. Higgins, and J. B. O. Taylor: Role and control of eicosanoid in acute non-immune inflammation in the equine
    • Lloyd N. Fleisher: Eicosanoids and ocular inflammation
  • Section III - Calcium Channel Blockers
    • Mark D. Kittleson: Calcium channel blocking drugs in cardiology: clinical aspects
    • Robert L. Hamlin: Clinical and experimental studies with verapamil in the dog
    • Mark D. Kittleson, Bruce W. Keene, and Jerry A. Woodfield: The acute therapy of supraventricular tachycardia with verapamil
  • Section IV - Research Session
    • K. J. Varma, P. E. Adams, R. D. Lobell, J. F. Lamendola, J. W. Houdeshell, and T. E. Powers: Pharmacokinetics of florfenicol in veal calves and its in vitro antibacterial activity
    • Scott Anthony Brown and Gordon L. Coppoc: Tissue residues of aminoglycoside antibiotics in sheep
    • P. D. Pion, J. Babish, W. Schwark, and W. Hornbuckle: Pharmacokinetics and electrocardiographic effects of verapamil in the cat
    • M. J. Novotny, M. H. Laughlin, and H. R. Adams: Endotoxic shock in the dog: effects of allopurinol, catalase, and superoxide dismutase
    • Judith K. Gwathmey and James P. Morgan: Subcellular mechanisms of inotropic agents
    • G. G. Knowlen and M. D. Kittleson: Drug trials in spontaneous cardiomyopathy in dogs: problems and solutions
  • Section V - Oxygen Free Radicals
    • Olen R. Brown: Biology of oxygen radicals: an overview
    • Matthew B. Grisham: Oxidative mechanisms of neutrophil-mediated cytotoxicity
    • Ronald J. Korthuis: Ischemia-reperfusion injury: role of oxygen radicals
  • Section VI - Future Developments in the Pharmaceutical Industry
    • David F. Kowalczyk: Peptide pharmaceuticals
    • Bruce A. Peters, William I. Cox, and Kent Van Campen: Immunopharmacology: biological response modifiers (BRMs)
    • L. A. Babiuk, M. J. P. Lawman, G. A. Gifford, and H. Bielefeldt Ohmann: Interferon: an application of recombinant DNA technology in bovine respiratory disease
    • Judi Weissinger: Advances in pharmacologic applications at the Center for Veterinary Medicine
  • Section VII - Teaching Veterinary Pharmacology
    • Lloyd E. Davis and Arthur L. Aronson: Teaching veterinary pharmacology and therapeutics for the next decade
    • Charles R. Short and Carl E. Aronson: Teaching pharmacology and toxicology as basic sciences in the veterinary medical curriculum
    • P. Lees: Teaching and research in veterinary pharmacology and therapeutics in the United Kingdom during the next decade
    • Jeff R. Wilcke: Development of clinical pharmacology over the next decade
    • Glen F. Hoffsis: The need to change our approach to teaching of therapeutics in the food animal sector